ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $452,000 | -85.8% | 12,150 | -80.5% | 0.01% | -86.4% |
Q2 2020 | $3,189,000 | +62.7% | 62,150 | 0.0% | 0.04% | +41.9% |
Q1 2020 | $1,960,000 | -48.6% | 62,150 | 0.0% | 0.03% | -18.4% |
Q4 2019 | $3,813,000 | +64.7% | 62,150 | -1.6% | 0.04% | +52.0% |
Q3 2019 | $2,315,000 | -21.2% | 63,135 | 0.0% | 0.02% | -21.9% |
Q2 2019 | $2,938,000 | +46.3% | 63,135 | +26.3% | 0.03% | +45.5% |
Q1 2019 | $2,008,000 | – | 50,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |